Bio-Rad Laboratories, Inc. (BIO)
After hours:
| Previous close | 304.92 |
| Open | 305.00 |
| Bid | 239.12 x 800 |
| Ask | 336.67 x 800 |
| Day's range | 300.98 - 308.27 |
| 52-week range | 261.59 - 509.62 |
| Volume | |
| Avg. volume | 250,960 |
| Market cap | 8.947B |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Bio-Rad Reports Third-Quarter 2023 Financial Results
HERCULES, Calif., October 26, 2023--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30, 2023.
- Business Wire
Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
HERCULES, Calif., October 05, 2023--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, will report its financial results for the third quarter of 2023 on Thursday, October 26, 2023, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
- Business Wire
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
HERCULES, Calif., August 28, 2023--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during Wells Fargo’s 2023 Healthcare Conference on Thursday, September 7 at 11:00 AM Eastern Time (8:00 AM Pacific Time).
